X

Trial Profile

A Phase 1/2 clinical trial of AVR-RD-03 in Pompe's disease

Status: Planning

Phase of Trial: Phase I/II

Latest Information Update: 24 Jul 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs AVR RD 03 (Primary)
Indications Glycogen storage disease type II
Focus Adverse reactions
Sponsors AVROBIO; Tectonic Therapeutic

Most Recent Events

20 Jun 2024 According to a Tectonic Therapeutic media release, AVROBIO has been merged with Tectonic Therapeutic to form Tectonic Therapeutic.
17 Mar 2022 According to a AVROBIO media release, the company plan to engage with regulatory agencies on the clinical development strategy and plan to initiate this clinical trial in 2023, subject to regulatory clearance.
04 Jan 2022 According to a AVROBIO media release, the company plans to initiate this trial in 2022.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com